Pandeia Therapeutics Limited
- Company number
- 11463856
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 13 Jul 2018
- Nature of business
- Research and experimental development on biotechnology
Registered office
The Cambridge Partnership The Dorothy Hodgkin Bldg Babraham Research Campus
Babraham
Cambridge
CB22 3FH
Babraham
Cambridge
CB22 3FH
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Martin Quibell | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
5 Mar 2019 | 5 Mar 2019 |
| Dr Fraser Murray | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
5 Mar 2019 | 5 Mar 2019 |
| Dr Timothy Schulz-Utermoehl | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
13 Jul 2018 | 20 Sep 2019 |
| Medicxi Ventures I Lp | Ownership Of Shares 75 To 100 Percent | 20 Sep 2019 | 22 Dec 2022 |
| Acadia Pharmaceuticals Inc. | Ownership Of Shares 75 To 100 Percent | 22 Dec 2022 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2024 | -£3,214,073 | £222,751 | 1 |
| 31 Dec 2023 | -£1,295,422 | £178,617 | 3 |
| 31 Aug 2022 | - | £796,269 | 3 |
| 31 Dec 2021 | - | £1,525,884 | 3 |
| 31 Dec 2020 | - | £364,357 | 1 |
| 31 Dec 2019 | - | £1,385,926 | 1 |